Scilex Holding Company Increase (Decrease) in Accounts Receivable
Scilex Holding Company (SCLX) reported Increase (Decrease) in Accounts Receivable of -$8.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- Scilex Holding Company increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$4.13M, a 167.26% decline year-over-year.
- Scilex Holding Company increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$4.60M.
- Scilex Holding Company increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $664.00K, a 91.80% decline year-over-year.
- Scilex Holding Company increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$4.83M.
- Scilex Holding Company increase (decrease) in accounts receivable for fiscal 2025 was -$13.84M, a 320.79% decline from fiscal 2024.
- Scilex Holding Company increase (decrease) in accounts receivable for fiscal 2024 was $6.27M, a 53.09% decline from fiscal 2023.
- Scilex Holding Company increase (decrease) in accounts receivable for fiscal 2023 was $13.36M, a 91.75% increase from fiscal 2022.
- Scilex Holding Company increase (decrease) in accounts receivable for fiscal 2022 was $6.97M, a 510.16% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$8.73M 10-Q · filed 2026-08-14 | -$8.07M derived: sum of 3 quarters · filed 2026-08-14 | -$12.89M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$4.60M 10-Q · filed 2026-05-20 | -$3.93M derived: sum of 2 quarters · filed 2026-05-20 | -$8.76M derived: sum of 3 quarters · filed 2026-05-20 | -$2.61M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $664.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$4.16M derived: sum of 2 quarters · filed 2026-04-10 | $1.99M derived: sum of 3 quarters · filed 2026-08-14 | -$13.84M 10-K · filed 2026-04-10 |
| 2025-09-30 | -$4.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.32M derived: sum of 2 quarters · filed 2026-08-14 | -$14.50M 10-Q · filed 2025-11-14 | -$6.40M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $6.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$9.68M 10-Q · filed 2026-08-14 | -$1.58M derived: sum of 3 quarters · filed 2026-08-14 | -$6.82M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$15.82M 10-Q · filed 2026-05-20 | -$7.72M derived: sum of 2 quarters · filed 2026-05-20 | -$12.96M derived: sum of 3 quarters · filed 2026-05-20 | -$4.67M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $2.86M derived: sum of 2 quarters · filed 2026-04-10 | $11.15M derived: sum of 3 quarters · filed 2026-04-10 | $6.27M 10-K · filed 2026-04-10 |
| 2024-09-30 | -$5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $3.05M derived: sum of 2 quarters · filed 2025-11-14 | -$1.83M 10-Q · filed 2025-11-14 | $16.34M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $3.41M 10-Q · filed 2025-08-13 | $21.58M derived: sum of 3 quarters · filed 2025-08-13 | $10.44M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$4.88M 10-Q · filed 2025-05-14 | $13.29M derived: sum of 2 quarters · filed 2025-05-14 | $2.15M derived: sum of 3 quarters · filed 2025-05-14 | $10.47M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $18.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $7.03M derived: sum of 2 quarters · filed 2025-03-31 | $15.35M derived: sum of 3 quarters · filed 2025-03-31 | $13.36M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$11.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | -$2.82M derived: sum of 2 quarters · filed 2025-01-17 | -$4.81M 10-Q · filed 2025-01-17 | -$1.05M derived: sum of 4 quarters · filed 2025-01-17 |
| 2023-06-30 | $8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $6.33M 10-Q · filed 2024-08-13 | $10.09M derived: sum of 3 quarters · filed 2024-08-13 | $11.67M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$1.99M 10-Q · filed 2024-05-13 | $1.77M derived: sum of 2 quarters · filed 2024-05-13 | $3.34M derived: sum of 3 quarters · filed 2024-05-13 | $3.83M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $5.34M derived: sum of 2 quarters · filed 2024-03-12 | $5.82M derived: sum of 3 quarters · filed 2024-03-12 | $6.97M 10-K · filed 2024-03-12 |
| 2022-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.06M derived: sum of 2 quarters · filed 2023-11-14 | $3.21M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $488.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.63M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $1.14M 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $1.14M 10-K · filed 2024-03-12 | |||
| 2020-12-31 | $598.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |